pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
tagmokitug
Adenocarcinoma Of The Gastroesophageal Junction
$CHRSCoherus Oncology, Inc.
0 catalysts
Phase 2
tagraxofusp
Elzonris (tagraxofusp-erzs)
Refractory Acute Myeloid Leukemia
Elongation factor 2Interleukin-3 receptor subunit alpha
Stemline Therapeutics Inc
0 catalysts
Phase 2
tambiciclib
Diffuse Large B-Cell Lymphoma
$SLSSELLAS Life Sciences Group, Inc.
← prev
page 47 of 50
next →
131
Pain89
Neurology1
0 catalysts
Phase 2
tambotatug pelitecan
Nasopharyngeal Cancer
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
tasquinimod
tasquinimod [INN]
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Active Biotech AB
0 catalysts
Phase 2
taurine
taurine [INN]
Homocystinuria
University of Colorado Denver
0 catalysts
Phase 2
tebapivat
Sickle Cell Disease
$AGIOAGIOS PHARMACEUTICALS, INC.
0 catalysts
Phase 2
tegavivint
tegavivint [INN]
Hepatocellular Carcinoma
Iterion Therapeutics Inc
0 catalysts
Phase 2
tegoprubart
Pancreatic Islet Transplant Rejection
CD40 ligand
$ELDNEledon Pharmaceuticals, Inc.
0 catalysts
Phase 2
telacebec
Buruli Ulcer
Qurient Co Ltd
0 catalysts
Phase 2
telisotuzumab adizutecan
telisotuzumab adizutecan [INN]
Gastric Cancer
$ABBVAbbVie Inc.
0 catalysts
Phase 2
terbinafine hydrochloride
Terbinafine Hydrochloride (terbinafine hydrochloride)
Onychomycosis (Tinea Unguium)
Squalene monooxygenase
Hallux Inc
0 catalysts
Phase 2
teropavimab
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 2
tertomotide
tertomotide [INN]
Alzheimer's Disease
GemVax & KAEL Co Ltd
0 catalysts
Phase 2
testosterone
Testagen TDS (testosterone [INN])
Male Hypogonadism
Transdermal Delivery Solutions Corp
0 catalysts
Phase 2
testosterone tridecanoate
Sarcopenia
$LPCNLipocine Inc.
0 catalysts
Phase 2
tianeptine
tianeptine [INN]
Rett Syndrome
AMO Pharma Ltd
0 catalysts
Phase 2
tibulizumab
Hidradenitis Suppurativa
Interleukin-17ATumor necrosis factor ligand superfamily member 13B
$ZURAZura Bio Ltd
0 catalysts
Phase 2
tigilanol tiglate
Angiosarcoma
Protein kinase C (PKC)
QBiotics Group Ltd
0 catalysts
Phase 2
timolol
Ocular Hypertension
Beta-1 adrenergic receptorBeta-2 adrenergic receptor
Betaliq Inc
0 catalysts
Phase 2
tipelukast
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$MNOVMEDICINOVA INC
0 catalysts
Phase 2
tirapazamine
Colorectal Cancer
Teclison Ltd
0 catalysts
Phase 2
tisolagiline
tisolagiline [INN]
Dementia Associated With Alzheimer's Disease
$SCLXScilex Holding Co
0 catalysts
Phase 2
tivozanib
Wet (Neovascular / Exudative) Macular Degeneration
Platelet-derived growth factor receptor betaVascular endothelial growth factor receptor
Kyowa Kirin Co Ltd
0 catalysts
Phase 2
tolcapone
Tolcapone Oceanside (tolcapone)
Amyloidosis
Catechol O-methyltransferase
Corino Therapeutics Inc
0 catalysts
Phase 2
tolimidone
Type 2 Diabetes
Tyrosine-protein kinase Lyn
Melior Pharmaceuticals I Inc
0 catalysts
Phase 2
tominersen
Huntington Disease
Huntingtin mRNA
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
tonabersat
Xiflam (tonabersat [INN])
Diabetic Nephropathy
Inflammx Therapeutics Inc
0 catalysts
Phase 2
topotecan
HYCAMTIN (topotecan [INN])
Retinoblastoma
Targeted Therapy Technologies LLC
0 catalysts
Phase 2
tosposertib
tosposertib [INN]
Solid Tumor
TiumBio Co Ltd
0 catalysts